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Abstract: In practice, nutrition recommendations vary widely for inpatient and discharge
management of acute, uncomplicated diverticulitis. This systematic review aims to review the
evidence and develop recommendations for dietary fibre modifications, either alone or alongside
probiotics or antibiotics, versus any comparator in adults in any setting with or recently recovered
from acute, uncomplicated diverticulitis. Intervention and observational studies in any language
were located using four databases until March 2017. The Cochrane Risk of Bias tool and GRADE were
used to evaluate the overall quality of the evidence and to develop recommendations. Eight studies
were included. There was “very low” quality evidence for comparing a liberalised and restricted fibre
diet for inpatient management to improve hospital length of stay, recovery, gastrointestinal symptoms
and reoccurrence. There was “very low” quality of evidence for using a high dietary fibre diet as
opposed to a standard or low dietary fibre diet following resolution of an acute episode, to improve
reoccurrence and gastrointestinal symptoms. The results of this systematic review and GRADE
assessment conditionally recommend the use of liberalised diets as opposed to dietary restrictions
for adults with acute, uncomplicated diverticulitis. It also strongly recommends a high dietary fibre
diet aligning with dietary guidelines, with or without dietary fibre supplementation, after the acute
episode has resolved.
Keywords: dietary fibre; diverticulitis; diverticulosis; diverticular disease; systematic review; bowel
rest; dietary restriction; probiotic
1. Introduction
Diverticulitis is characterised by the acute inflammation and/or infection of diverticula in the
colonic wall, often managed by hospitalisation for administration of intravenous antibiotics, dietary
fibre modifications and monitoring [1,2]. The incidence, prevalence, and number of hospital admissions
are rapidly increasing due to a rising prevalence of risk factors such as ageing, increasing central
adiposity, sedentary lifestyles, and low diet quality [3–5]. Outpatient visits to physicians for diverticular
disease are over 2.5 million annually in the United States of America [6], and the 300,000 annual hospital
admissions for acute diverticulitis alone has a financial burden of USD$2.5 billion (£1.9 billion) [7].
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Therefore, it is the timely treatment, prevention of reoccurrence of acute episodes, and decreased
gastrointestinal symptoms which are important for improving patient and healthcare outcomes
worldwide [8,9].
Upon diagnosis of acute, uncomplicated diverticulitis (i.e., no perforation, non-localised abscess,
drains placed, or surgery required), short-term low dietary fibre intake or food deprivation for bowel
rest is often used in clinical practice as it is thought that a less active bowel reduces colonic irritation
and re-inflammation [10,11]. These treatment options are usually administered in the inpatient setting,
but may also be provided as outpatient care. The efficacy of these treatment approaches in acute,
uncomplicated diverticulitis have not yet been reviewed, and dietary fibre restrictions (herein referred
to as a “restricted diet”) may be associated with longer hospital stay, increased patient burden, increased
risk of malnutrition especially in older adults, and increased health care costs [12–14]. In addition to
delaying recovery, there is evidence suggesting bowel rest in acute diseases of the colon is ineffective
in reducing inflammation, risk of infection and other complications [15,16].
Following resolution of acute symptoms, patients are frequently recommended to follow a low
dietary fibre diet and then transition to a standard or high dietary fibre diet (defined as meeting or
exceeding national nutrient recommendations for age and gender) [17,18]. A high dietary fibre diet
is hypothesised to prevent diverticulitis reoccurrence due to reducing the contact time between gut
contents and diverticula, and the associated irritation [19–21]. There has also been increasing use of
probiotic supplementation in practice, which is thought to decrease risk of infection and inflammation
of the diverticula [22]. However, this practice has not yet been evaluated by a systematic literature
review. A 2012 systematic review found no intervention studies which modified dietary fibre intake to
prevent acute diverticulitis reoccurrence [23]. A second, more recent systematic review examined the
efficacy of dietary fibre modifications for management of symptomatic uncomplicated diverticular
disease (SUDD); however, did not address management of acute diverticulitis, a complication of
SUDD [24]. The lack of information about what dietary recommendations should be given to patients
with acute diverticulitis is reflected by inconsistent guidelines [1,2], and is likely to have important
clinical implications, including increased patient burden and health service use [10].
Therefore, this study aims to systematically review observational and intervention evidence
and develop preliminary recommendations for dietary fibre modifications, either alone or alongside
probiotics and/or antibiotics, versus any comparator on recovery, reoccurrence, gastrointestinal
symptoms and health care use for adults during or following an episode of acute, uncomplicated
diverticulitis in any health care setting. Based on an exploratory literature review, hypotheses are that
a liberalised diet is equal to a restricted diet for the outcomes of recovery, gastrointestinal symptoms,
and reoccurrence, and superior in regards to health care use and costs. It is also hypothesised that after
an acute episode has resolved, high dietary fibre intake (i.e., meeting nutrient reference values and
dietary guidelines) and/or probiotic supplementation is superior to a standard (i.e. returning to the
individual’s previous diet) or low fibre diet in regards to reoccurrence, gastrointestinal symptoms and
health care use.
2. Materials and Methods
This systematic review was reported according to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement [25]. The study protocol was registered with the
International Prospective Register of Systematic Reviews (PROSPERO Number: CRD42016048741).
2.1. Study Search and Selection
The electronic databases Medline (PubMed), Embase, Web of Science and CINAHL were searched
for published literature in any language from database inception until the 31 March 2017, using
a combination of keywords and controlled vocabulary adapted for each database. The full search
strategy is shown in Online Supplementary Material 1. Briefly, the approach used for the search
strategy was based on the following: (dietary fibre OR fibre OR carbohydrates OR starch OR diet* OR
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nutrition* OR residue OR roughage OR prebiotic* OR fasting OR food deprivation OR bowel rest OR
nil by mouth OR conservative) AND (Diverticu*).
A snowballing strategy was also used whereby reference lists of included studies, reviews and/or
guideline documents were searched to identify additional studies not found in the search strategy;
and a brief targeted search of Google Scholar was conducted.
Studies were included with adults (≥18 years) diagnosed with acute, uncomplicated diverticulitis,
characterised by the absence of large or pelvic abscess, fistula, stricture, peritonitis, sepsis and
surgery. Patients were included if interventions were implemented during the acute episode, or in the
post-acute period (directly after acute inflammation and pain has subsided and the case is considered
treated) to manage ongoing symptoms and prevent reoccurrence. Studies were included only where
participants received dietary or supplemental fibre modifications (restriction or increase), including the
implementation of bowel rest or liquid diets, with or without probiotic supplementation or antibiotic
administration, in the any health care setting (inpatient or outpatient). Study populations that had
diverticular disease or diverticulosis, without an episode of acute, uncomplicated diverticulitis, were
excluded from this review and were reported elsewhere [26]. As there are very few randomised
controlled trials examining the research questions, eligible study designs included prospective and
retrospective intervention studies of any design and observational longitudinal studies. Ineligible
study designs were cross-sectional studies, reviews, abstracts, study protocols, and conference papers,
or those that did not report on any outcome of interest.
Eligible studies were then selected in a two-stage process. At Stage 1, the titles and abstracts of
identified studies were screened for eligibility by two independent researchers (CD and MC). At Stage
2, the full text of potentially eligible articles were retrieved and independently reviewed for eligibility
by two researchers (CD and MC), with the final selection discussed and agreed upon by consensus.
2.2. Outcome Measures
To reflect the management of an acute episode of uncomplicated diverticulitis, hospital length of
stay (LOS) was considered the primary outcome variable of interest; and secondary outcomes were
diverticulitis reoccurrence, direct health service costs, recovery (indicated by incidence of treatment
failures; defined as no clinical improvement with therapy or development of complications), quality of
life, and gastrointestinal symptoms. Outcome measures were considered 24-h after presentation to
five-years post-diagnosis.
To reflect management of acute, uncomplicated diverticulitis after the acute episode has resolved
(absence of clinical signs and symptoms within any timeframe from initial acute episode), the primary
outcome of interest was reoccurrence of acute diverticulitis (uncomplicated or complicated) within
five years. Secondary outcomes were health care costs, quality of life, gastrointestinal symptoms, and
outpatient medical visits regarding gastrointestinal concerns. Primary and secondary outcomes were
considered from the resolution of the initial acute episode to five-years post episode.
Data relating to the sample population, intervention, comparator, and reported findings were
extracted and reported qualitatively. The data extraction was conducted independently by two
researchers (CD and MC), where all included studies were checked for accuracy by a senior researcher
(S Marshall). Where continuous data was not reported as means and standard deviations, Review
Manager was used to compute these (Review Manager (RevMan) [computer program]. Version 5.3.
Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014).
2.3. Study Strength and Quality of the Evidence
Internal study quality of all included studies was assessed using the Cochrane risk of bias
tool independently by two researchers (CD and MC); and reviewed for accuracy by a senior
researcher (S Marshall) [27]. The certainty in the body of evidence for each outcome of interest
and the development of recommendations for populations were developed using the Grading of
Recommendations, Assessment, Development and Evaluation (GRADE) tool [28], following steps
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and interpretation as specified in the GRADE Handbook [29] and implemented using the software
GRADEpro GDT (GRADEpro Guideline Development Tool, McMaster University, 2015, developed
by Evidence Prime, Inc. Hamilton, Canada). Determination of the GRADE level of evidence was
determined independently by two authors (CD and S Marshall), with disagreements managed
by consensus. The factors that determine the direction and strength of recommendations for the
clinical question considered a balance between desirable and undesirable outcomes, confidence in
the magnitude of estimates of effect, confidence in values and preferences of stakeholders and the
resources/feasibility of the recommendations [29]. The recommendations and justifications were
developed in panel discussions with all authors of this review.
2.4. Meta-Analysis
Meta-analysis was unable to be performed due to high heterogeneity among included studies.
3. Results
The electronic search identified 5524 records, where snowball searching identified a further
eight studies (Figure 1). There were 111 papers retrieved for full text review, with 8 included in the
qualitative analysis (Table 1andTable 2).
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Table 1. Study characteristics and outcomes of studies with dietary fibre modifications in adults with acute, uncomplicated diverticulitis.
Study Setting Study Design Population Intervention Comparator Results
Ridgway et al.
[31]
• Ireland
• n = two general
hospitals
• Data collected
2002–2004.
• RCT
• Allocation
method:
randomised 1:1
• Diagnosis: Acute,
Uncomplicated
Diverticulitis
• Diagnostic method:
Diagnosis inferred
from left iliac fossa
pain and local
tenderness (Hinchey a
type I and II).
• n = 79 participants;
58% female
• µ age 66–68 years
(range 31–86).
Inpatient treatment
liberalised diet (“food and
fluid as tolerated”) + oral
abx upon admission
(Ciprofloxacin 500 mg BD +
Metronidazole 400 mg TDS).
n = 41 participants
Inpatient treatment bowel rest
(NBM) and IV fluids for 24 h
with progression to full diet
as tolerated according to daily
physician consultations + oral
abx introduced after 24 h
(Ciprofloxacin 400 mg BD +
Metronidazole 500 mg TDS).
n = 38 participants
Hospital LOS:
• No difference between groups: liberalised diet µ5.5
(±1.9 b) days vs bowel rest µ6.6 (±4.1 b) days; P = 0.12.
Reoccurrence: 30-day readmission rate:
• Acute uncomplicated diverticulitis n = participants (%)
- liberalised diet group = 1/41 (2.4%)
- bowel rest group = 1/38 (2.6%)
Not compared statistically
Gastrointestinal symptoms: Wexford Tenderness Score
(score 0–4; higher score indicates higher tenderness/rigidity)
at 3-days post-admission:
• No difference between groups: liberalised diet µ1.26 vs.
bowel rest µ1.20; P = 0.79
Recovery: no treatment failures (cessation of oral
therapy/crossovers) identified in either group.
Park et al.
[30]
• South Korea
• Unknown
number and
type of
recruitment sites
• Data
collected 2007–2009.
• Prospective
observational
cohort study
• Allocation
method: patient
chose from
treatment options
• Diagnosis: Acute, right
colonic uncomplicated
diverticulitis
• Diagnostic method:
Radiologic
identification of
inflamed diverticulum
and small
abscess formation
• n = 103 participants;
51% female
• µ age 37–40
(±10–14) years
Outpatient treatment
liberalised diet + of 4-days
of oral abx (second
generation cephalosporins
and metronidazole, with
progression to ciprofloxacin
monotherapy if adverse
event suspected; not further
specified)
n = 40 participants
Inpatient treatment with
bowel rest (nil by mouth)
until symptom resolution
followed by full diet (unclear
if progressive stages or
immediate move to full diet) +
7–10 days of IV abx (second
generation cephalosporins
and metronidazole, with
progression to ciprofloxacin
monotherapy if adverse event
suspected; not further
specified)
n = 63 participants
Hospital LOS:
• µ8.1 ± 1.3 days in bowel rest + IV abx group; no
comparator as outpatient group seen in
outpatient clinic.
Reoccurrence: measured up to 21 months post-diagnosis:
• Acute uncomplicated diverticulitis n = participants (%)
- liberalised diet group = 4/40 (10%)
- bowel rest group = 7/63 (11%)
No difference between groups; P = 0.808.
Outpatient visits: visits to the outpatient clinic within
1-week post-diagnosis:
• n = 2/40 in outpatient group 3-days after diagnosis. No
comparator as inpatient group seen as inpatients.
Health care costs: items included and currency not
described; assumed USD:
• Liberalised diet and oral abx had significantly lower
medical cost compared to bowel rest and IV abx
(µ$1164 ± 128 vs. µ1789 ± 152; P < 0.001).
Recovery: Treatment failure (no response to therapy):
• Liberalised diet and oral abx n = 2 vs. bowel rest and
IV abx n = 0. Not compared statistically.
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Table 1. Cont.
Study Setting Study Design Population Intervention Comparator Results
van de Wall
et al. [12]
• Netherlands
• Unknown
number and
type of
recruitment
sites
• Data collected
2010–2011
• Retrospective
observational
cohort study
• Allocation
method:
Observation of
physician
treatment
decisions.
• Diagnosis: Acute,
uncomplicated
diverticulitis
• Diagnostic method:
Modified Hinchey
0/Ia/b confirmed by
CT-scan or sonography
• n = 256 participants;
57% female
• µ age 57–60
(±12–15) years
Inpatient liberalised diet +
26% treated with abx (not
further specified) n = 27
participants
Inpatient bowel rest (NBM) +
40% treated with abx (not
further specified). Followed
by a median of 3 (range 2–4)
successive inpatient diet
regimens. n = 65 participants
Hospital LOS
• Lower in the liberalised diet compared to bowel rest
(median 3 [range 2–4] days vs median 5 [range 1–16]
day; not compared statistically)
• Liberalised diet two times more likely to be discharged
compared to bowel rest in multivariate model (HR: 2.04
[95%CI: 1.27–3.29]; P=0.003).
Recovery: treatment failure (development of complications
including abscess, perforation or requiring surgery):
• n = 0/27 (0%) in liberalised diet, n = 2/65 (3.1%) in
bowel rest group.
Not compared statistically.
Inpatient liberalised diet +
26% treated with abx (not
further specified)
Inpatient restricted diet: clear
liquids + 28% treated with
abx (not further specified).
Followed by a median of 3
(range 1–3) successive
inpatient diet regimens.
n = 89 participants
Hospital LOS
• Lower in the liberalised diet compared to clear liquid
diet (median 3 [range 2–4] days vs median 4 [range
1–15] day; not compared statistically)
Recovery: treatment failure (development of complications
including abscess, perforation or requiring surgery):
• n = 0/27 (0%) in liberalised diet, n = 3/89 (3.4%) in
clear liquid group.
Not compared statistically.
Inpatient liberalised diet +
26% treated with abx (not
further specified)
Inpatient restricted diet:
liquids + 32% treated with
abx (not further specified).
Followed by a median of 2
(range 1–2) successive
inpatient diet regimens.
n = 75 participants
Hospital LOS
• No difference in the liberalised diet compared to liquid
diet (median 3 (range 2–4) days vs median 3 (range 1–8)
day; not compared statistically)
Recovery: treatment failure (development of complications
including abscess, perforation or requiring surgery):
n = 0/27 (0%) in liberalised diet, n = 1/75 (1.3%) in liquid
group; not compared statistically.
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Table 1. Cont.
Study Setting Study Design Population Intervention Comparator Results
Moya et al.
[32]
• Spain
• n = 1
general hospital
• Data
collected 2007–2009
• Historically-
controlled
intervention
study
• Allocation
method:
consecutive
admissions
within defined
time-period
(group 1 in
2007–2008;
group 2 in
2008–2009).
• Diagnosis: Acute,
uncomplicated
diverticulitis
• Diagnostic method:
physical examination
with CT confirmation
• n = 76 participants;
53% female
• µ age 56–59 (range
32–84 years)
Outpatient treatment:
Restricted diet (liquid only)
for 4-days followed by low
dietary fibre diet for 3-days
with high dietary fibre diet
+ oral abx (Metronidazole
500 mg/8 h and
Ciprofloxacin 500 mg/12 h)
+ IV analgesics
(Acetaminophen 1 g/6 h).
Patients reviewed by
physician for need of
hospitalisation.
n = 32 participants
Inpatient treatment:
Restricted diet (liquid only)
for 3-days followed by low
dietary fibre diet for 2-days
with high dietary fibre diet
upon discharge (5-days post
diagnosis) + IV abx
(Metronidazole 500 mg/8 h
and Ciprofloxacin
400 mg/12 h) + IV analgesics
(Acetaminophen 1 g/6 h) for
5-days followed by oral abx
(Metronidazole 500 mg/8 h
and Ciprofloxacin
500 mg/12 h) for 7-days
n = 44 participants.
Hospital LOS:
• Outpatient treatment had significantly lower LOS than
inpatient treatment (µ0.28 days vs. µ5.8 vs. days;
P < 0.05).
Reoccurrence: subsequent presentation and diagnosis
within average 8–9-months post-diagnosis:
• Acute uncomplicated diverticulitis n = participants (%)
- outpatient diet group = 2/34(5.9%)
- inpatient diet group = 3/44(6.8%)
No difference between groups; P = 0.86.
Health care costs: direct health costs include ward
accommodation, pharmaceutical treatment, laboratory tests
and radiology:
• Outpatient treatment cost significantly less than
inpatient treatment (µ€347.31 vs. µ€1945.26; P < 0.05).
Stam et al.
[13]
• Netherlands
• n = 1 teaching
hospital
• Data
collected 2012–2014
• Prospective
observational
study
• Allocation
method: One
group only
• Diagnosis: Acute,
uncomplicated
diverticulitis
• Diagnostic method:
Modified Hinchey Ia/b
• n = 86 participants;
47% female
• µ age 55 (±12) years
Outpatient treatment
liberalised diet (no
restrictions of any kind) c +
analgesics (acetaminophen
or opioids if pain score over
40 on scale 0–100) +
iso-osmotic laxative. Nil
abx. Patients reviewed by
physician for need of
hospitalisation.
N/A
Outcomes assessed 6-months post-diagnosis.
Hospital admission rate: at the time of first diagnosis:
• n = 29 (34%) admitted
Hospital LOS: for first diagnosis:
• 1.8 ± 0.3 days for the 34% admitted.
Reoccurrence: subsequent presentation and diagnosis
between 3–6 months after initial diagnosis:
• n = 4 (5%)
• Recovery: treatment failure (defined by review authors
as surgery, readmissions due to pain or recurrence up
to 6 months post discharge) n = 2 (2%)
abx, antibiotics; CT, computed tomography; HR, Hazard Ratio; IV, intravenous; LOS, length of stay; NBM, nil by mouth; RCT, randomised controlled trial. a Hinchey classification is
a tool used to describe successive stages of perforations (severity) of diverticulitis [33]; b This study reported standard errors; however, we have reported standard deviations, calculated
by Review Manager; c Not all patients with acute, uncomplicated diverticulitis were given liberalised diet and recruited: there were n = 70 patients excluded from participating due
patient-reported inability to tolerate any oral intake; need for antibiotics, immunocompromised; declined participation; and suspicion of inflammatory bowel disease or malignancy.
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Table 2. Study characteristics and outcomes of studies that compare dietary modifications to increase dietary fibre for the management of uncomplicated diverticulitis
after the acute episode has resolved.
Study Setting Study Design Population Intervention Comparator Results
Taylor and
Duthie [35]
• UK
• Unknown
number and
type of
recruitment sites
• Data collected:
dates
not specified
• Three-arm
randomised
cross-over
intervention
study
• Allocation
method:
random
allocation (not
further
described).
*
• Diagnosis:
symptomatic
diverticular disease;
40% with recent acute,
uncomplicated
diverticulitis
• Diagnostic method:
barium enema.
• n = 20 participants.
• Gender and age not
reported.
One month of high fibre
diet (termed high-roughage
diet) with 18 g dietary fibre
from supplements (9 × 2 g
bran tables per day).
Written educational
material provided for
high-roughage diet.
One month of dietary fibre
supplement with laxative
(Normacol: sterculia with
frangula bark—dosage not
specified) with
anti-spasmodic
Gastrointestinal symptoms: at one-month post
intervention: gastrointestinal symptom scores (scale 0–17;
higher score indicating worse symptoms):
• Score reported to improve in both groups
(data not provided).
Ongoing gastrointestinal symptoms
• High fibre diet + supplements had more participants
with ongoing symptoms compared to laxative group
(n = 10/13 [80%] vs. n = 8/13 [60%]). Not compared
statistically.
Stool weight:
• Increased in both groups but was not statistically
significant different between groups (high fibre diet +
supplements µ102 g ± S.E: 15.9 vs. normacol
µ105 ± 13.5).
Transit time:
• Decreased significantly in all groups but no difference
between groups (high fibre diet + supplements
µ76.4 ± S.E:7.2 h vs. normacol µ71.7 ± 10.9 h).
One month of 18 g dietary
fibre from supplements
(9 × 2 g bran tables per day)
with no education
regarding dietary change.
One month of dietary fibre
supplement with laxative
(Normacol: sterculia with
frangula bark—dosage not
specified) with
anti-spasmodic
Gastrointestinal symptoms: at one-month post
intervention: gastrointestinal symptom scores (scale 0–17;
higher score indicating worse symptoms):
• Score reported to improve in both groups
(data not provided).
Ongoing gastrointestinal symptoms
• Bran supplements had fewer participants with ongoing
symptoms compared to normacol group (n = 5/13
[40%] vs. n = 8/13 [60%]). Not compared statistically.
Stool weight:
• Stool weight statistically increased in both groups, and
bran supplement was statistically more effective in
increasing stool weight compared to the normacol
(µ121 g ± S.E:7.1 vs. µ105 ± 13.5)
Transit time:
• Decreased significantly in all groups, and bran
supplement was statistically more effective in
decreasing transit time compared to normacol
(µ56.1 ± S.E:4.1 h vs. µ71.7 ± 10.9 h; P < 0.05).
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Table 2. Cont.
Study Setting Study Design Population Intervention Comparator Results
One month of
high-roughage diet with 18
g dietary fibre from
supplements (9 × 2 g bran
tables per day). Written
educational material
provided for high-
roughage diet.
One month of 18 g dietary
fibre from supplements
(9 × 2 g bran tables per day)
with no education regarding
dietary change.
Gastrointestinal symptoms: at one-month post
intervention: gastrointestinal symptom scores (scale 0–17;
higher score indicating worse symptoms):
• Score reported to improve in both groups
(data not provided).
Ongoing gastrointestinal symptoms
• Bran supplements had fewer participants with ongoing
symptoms compared to high roughage diet +
supplements (n = 5/13 [40%] vs. n = 10/13 [80%]). Not
compared statistically.
Stool weight:
• Stool weight statistically increased in both groups, and
bran was statistically more effective in increasing stool
weight compared to the high fibre and supplement
group (µ102 g ± S.E: 15.9 vs. µ102 g ± S.E: 15.9)
Transit time:
• Decreased significantly in all groups, and bran
supplement was statistically more effective in
decreasing transit time compared to high fibre diet +
supplement (µ56.1 ± S.E:4.1 h vs. µ76.4 ± S.E: 7.2 h;
P < 0.001).
Leahy et al.
[36]
• UK
• n = 1
general hospital
• Data
collected: 1972–1981
• Retrospective
observational
cohort study
• Allocation
method: 76%
received high
fibre education
during
hospitalisation.
Others did not
receive for
unreported
reason.
• Diagnosis:
symptomatic,
uncomplicated
Diverticulitis requiring
hospitalisation (acute)
• Diagnostic method:
barium enema or
radiological
examination
+ symptoms
• n = 56 participants.
• Gender and age
not reported.
Adhering to a high fibre
diet (≥25 g dietary
fibre/day with or without
dietary fibre supplements)
2–11 years after initial
hospitalisation.
Education was initially
given during hospital
admission patient
counselled by medical and
dietetic staff with written
educational material. Other
in-hospital treatments not
described.
Low fibre diet (<25 g/day)
allocated by not adhering to
high fibre diet recommended
in hospital or were not
educated regarding high
fibre diet).
Reoccurrence: readmission rate at 54–76 months
post-diagnosis:
• Fewer reoccurrence of acute episode in high fibre diet
group than low fibre diet group (n = 2/31 [7%] vs.
n = 5/25 [20%]; P < 0.05).
Gastrointestinal symptoms: patient reported ongoing
symptoms (dichotomous, no scale/tool used) at 54–76
months post-diagnosis:
• High fibre group had fewer ongoing symptoms
compared to low fibre group (n = 6/22 [27%] vs.
n = 11/16 [69%]; P < 0.05).
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Table 2. Cont.
Study Setting Study Design Population Intervention Comparator Results
Lanas et al.
[34]
• Italy
• Multicentre: 23
gastroentero-logical centres.
• Data
collected: 2007–2008
• RCT
• Allocation
method:
computer
generated
random allocation
• Diagnosis: acute
diverticulitis (94%
uncomplicated), within
2 months prior
to recruitment
• Diagnostic method:
confirmed by CT scan,
ultrasonography
or endoscopy
• n = 165 participants;
37% female.
• µ 54–55 years (±12–13).
7 g dietary fibre
supplementation (3.5 g
plantago ovata husk
[psyllium]] consumed as
effervescent granulate BD)
consumed daily for 48
weeks. Dietary fibre
consumed from diet not
measured.
7 g dietary fibre
supplementation (3.5 g
plantago ovata husk
[psyllium]] consumed as
effervescent granulate BD)
consumed daily for 48 weeks
+ poorly absorbed oral abx
(400 mg rifaximin polymorph
alpha BD) consumed for one
week of each month for 48
week. Dietary fibre consumed
from diet not measured.
Reoccurrence: readmission rate at 48 weeks from baseline:
• Fewer reoccurrence of acute episode in supplement +
abx group than supplement alone group (n = 8/77
[10%] vs. n = 17/88 [19%]), compared statistically in
multivariate model (HR of reoccurrence in supplement
only group: 2.64 [95%CI: 1.08–6.46; P = 0.033).
Gastrointestinal symptoms: unknown score (scored 0–10,
10 worse symptoms; using visual analogue scale and
number of diarrhoea episodes) reflecting gastrointestinal
symptoms at 48 weeks from baseline:
• No improvement from baseline for both groups or
difference between groups at follow-up (supplement +
abx µ3.45 ± 7.03 vs supplement only group
µ3.26 ± 5.81); not compared statistically.
abx, antibiotics; CT, computed tomography; g, grams; h, hours; RCT, randomised controlled trial; S.E., standard error.
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All but two studies included had unclear or high risk of bias for four or more of the seven risk of
bias domains (Figure 2). The most common high risk of bias was due to inadequate randomisation
and blinding of participants (Online Supplementary Material 2).Nutrients 2018, 10, x FOR PEER REVIEW  5 of 20 
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ere ad inistered either oral or intravenous antibiotics in an inpatient setting, excepting the liberalised
diet groups by Park et al. [30] and Moya et al. [32] in which participants were outpatients. Both groups
in the st dy by Moya et al. [32] were given a restricted diet, and the studies by Park et al. [30] and
Moya et al. [32] varied the types of antibiotic given to patients, where intravenous antibiotics were
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given to inpatients and oral antibiotics given to outpatients. Stam et al. [13] also examined participants
in the outpatient setting; however, only one liberalised diet group was observed. No studies that
examined the treatment of acute, uncomplicated diverticulitis reported use of any intervention to
prevent reoccurrence after the treatment of the acute episode.
All studies reported hospital LOS; however, they could not be pooled due to poor reporting of
data, as well as a large skew of the LOS in most studies. However, as expected, LOS was reported
to be lower for liberalised diets compared to restricted diets in most studies. Although the RCT by
Ridgway et al. [34] found no significant decrease in LOS with aliberalised diet, this outcome may have
been underpowered given the wide standard deviation of the restricted diet group. The quality of the
evidence (GRADE) for hospital LOS was “very low” (Online Supplementary Material 3).
Both Park et al. [30] and Ridgway et al. [31] evaluated the impact of liberalised versus restricted
diets for the treatment of acute, uncomplicated diverticulitis on reoccurrence from 1 to 21 months
post discharge. It was concluded that there was no significant difference between liberalised and
restricted diets for reoccurrence, however, lack of consistent study design prevented data pooling
and meta-analysis.
Five comparisons evaluated the risk of treatment failures, from three studies: Park et al. [30],
Ridgway et al. [31], and three comparisons from van der Wall et al. [12], all of which reported low
incidence of treatment failures (<4 per group). There was large heterogeneity between studies, however,
based on the available evidence, there appears to be no difference in treatment failures in the liberalised
compared to the restricted diet groups.
The quality of the body of evidence comparing liberalised and restricted diets in regards to both
reoccurrence and recovery were assessed as “very low” (Online Supplementary Material 3). Only one
study reported on gastrointestinal symptoms comparing liberalised and restricted diets, finding no
difference between groups, with the quality of evidence being “very low” (Online Supplementary
Material 3).
3.2. Dietary Fibre Modifications with or without Probiotic Supplementation, for the Management of
Uncomplicated Diverticulitis after the Acute Episode Has Resolved
Three studies were identified that modified dietary fibre intake following an episode of acute,
uncomplicated diverticulitis (Table 2), including the study by Taylor and Duthie [35] that used
three intervention arms with no control group. No studies were identified that included probiotic
supplementation alone or in addition to dietary fibre modifications. Although all studies reported
on gastrointestinal symptoms and two reported on reoccurrence; no data could be pooled due to the
absence of low dietary fibre control groups in two of the three studies. The body of evidence regarding
a high dietary fibre diet and/or dietary fibre supplementation for both the prevention of reoccurrence
and improving gastrointestinal symptoms is “very low” (Online Supplementary Material 3).
4. Discussion
This systematic review found a lack of high quality interventional research examining the dietary
management of adults with acute, uncomplicated diverticulitis. However, the outcomes that could
be evaluated by observational and/or lower quality intervention research tended to agree with the
hypotheses that a liberalised and restricted diet are equal in terms of recovery (both having very low
risk and incidence of treatment failures), reoccurrence, and gastrointestinal symptoms, with liberalised
diets tending to have lower health care use. Therefore, this review found that available evidence
suggests liberalised diets for inpatient treatment are safe in uncomplicated cases. The “very low”
quality of the evidence comparing liberalised diets and restricted diets demonstrates that there is
no existing research showing any clinical benefit to implementing a diet restriction; and identified
no studies supporting the hypothesis that bowel rest is required for resolution of an acute episode
in uncomplicated cases. The interpretation of findings was limited by high clinical heterogeneity,
and results appear to be confounded by other intervention factors, such as differing antibiotics
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administration. Although one study was identified that used probiotics, it was not included as
modifications to dietary fibre intake were not described, and the probiotics were prescribed to both
intervention groups at the same dosage with only medications varied for comparison [22].
Despite a high risk of bias across most studies, and few studies examining the research questions,
the GRADE approach as outlined by Guyatt et al. [37] was used to review the quality of the body of
evidence and produce recommendations, which are discussed and justified briefly here. Research
evidence, discussion and detailed justifications for judgements supporting these recommendations can
be found in Online Supplementary Material 3.
4.1. Summary of Judgements and Recommendations for Liberalised versus Restricted Diets for the Inpatient
Dietary Management of Acute, Uncomplicated Diverticulitis
4.1.1. Recommendation for the Population
Adult patients admitted to hospital with acute, uncomplicated diverticulitis (i.e., no perforation,
non-localised abscess, drains placed or surgery required) should be placed on a liberalised diet
(i.e., allowing consumption of solid food) and not placed on a restricted diet (i.e., bowel rest/nil by
mouth, clear and/or liquid diets).
4.1.2. Strength of the Recommendation
Conditional recommendation for the intervention (liberalised diets) based on a very low-quality
body of evidence.
4.1.3. Overall Justification
This review identified no evidence of a difference between liberalised and restricted diets in
terms of clinical outcomes including recovery (treatment failures), reoccurrence or patient symptoms;
however, liberalised diets may decrease length of hospital stay and prevent restriction of essential
nutrient intake (e.g., dietary fibre, vitamins, minerals, phytonutrients, energy and protein found
in solid foods) in patients. It can be generally accepted that the majority of patients would prefer
autonomy and/or not to have food restrictions (such as nil by mouth or liquid only diets) prescribed
unless there is evidence of a medical contraindication. It can also be generally accepted that health
care providers would rather not place further nutrition restrictions on patients, which may require
increased dietary management by physicians, dietitians and/or nursing staff. Placing patients on
a liberalised diet is highly feasible. However, due to the poor quality and small amount of literature
examining this research question, this recommendation was conditional based on a low quality of
evidence. It should be highlighted that existing evidence suggests using a liberalised diet has a low
risk of harm and likely benefits to patients and the health care system. Despite a recommendation
in favour of liberalised diets, health care providers should consider the individual risk profiles of
patients to identify other potential contraindications for oral intake, such as co-morbidities or risk for
the development of complications (i.e., presence of bleeding, abscess or perforation).
4.1.4. Detailed Justification:
Values: It is generally accepted that patients and health care providers do not wish to impose
unnecessary dietary restrictions, which may cause patient and health care provider burden, increased
discomfort, decreased appetite, decreased nutrient intake, and increased risk of malnutrition for older
adults. It is generally accepted that decreased length of hospital stay is desirable for patients, health
care providers and health services.
Resources required: There are no resources required to implement the intervention; and there is
likely to be a saving of resources (staff time) by not implementing a restricted diet which can involve
multiple types of diet restrictions and which requires ongoing monitoring and evaluations.
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Cost effectiveness: There is no monetary cost to implement the intervention, but likely increased
costs to implement the comparison (restricted diet) through increased health care provider management
of dietary restrictions, and/or increased risk of complications associated with nutrient/food
deprivation (e.g., malnutrition).
Acceptability: A liberalised diet is likely to be acceptable to patients and health care providers.
Liberalised diets are not forcing the patient to eat if they do not wish to; it is simply offering autonomy
to consume food, allows more food options and minimises struggles over dietary compliance. It is
likely to require less health care resources and impose less burden on patients.
Subgroup considerations: Restriction of dietary intake in older adults (≥65 years), patients
with increased nutrient requirements, and those with food insecurity (e.g., financial insecurity or
drug/alcohol-dependence) should be minimised as much as possible due to their significantly higher
risk of malnutrition.
Implementation considerations: There are minimal implementation considerations. Implementation
of the intervention is simply not imposing any dietary restrictions.
Monitoring and evaluation: Patients should be monitored closely, as per current recommendations,
for signs of worsening condition and/or progression to complicated diverticulitis.
4.2. Summary of Judgements and Recommendations for a High Dietary Fibre Diet versus Low Dietary Fibre
or Standard Diets for the Dietary Management of Uncomplicated Diverticulitis after the Acute Episode
Has Resolved
4.2.1. Recommendation for the Population
Health care providers should recommend a long-term high dietary fibre intake (meeting the
nationally recommended intake for gender and age) after the acute episode of uncomplicated
diverticulitis has resolved.
4.2.2. Strength of the Recommendation
Strong recommendation for the intervention based on very low-quality body of evidence.
4.2.3. Overall Justification
This review found low confidence in the evidence that high dietary fibre intake will result directly
in improved risk for diverticulitis reoccurrence and/or gastrointestinal symptoms; but also found no
evidence supporting the use of a low dietary fibre diet. A high dietary fibre diet is recommended
as the standard diet for all adults by dietary guidelines [38,39], and therefore this recommendation
stands even though there is no strong confidence in added benefit for diverticulitis-related outcomes.
This recommendation is considered strong, based on very low-quality-evidence, as potential benefits
clearly outweigh risk, and support implementation of dietary guidelines [37]. Furthermore, a strong
recommendation based on very low quality of evidence aligns with recommendations made by
the American Society of Colon and Rectal Surgeons (ASCRS) for the medical management of acute
diverticulitis [17]. It should be recognised that achieving sustained dietary change is difficult in
western societies as it is not supported by the food environment [40], and therefore this diet should be
recommended along with long-term support to achieve dietary change [41]. The evidence shows some
improvement in clinical outcomes with the use of dietary fibre supplements with or without food-based
dietary fibre increases; however, there is insufficient evidence to make specific supplementation
recommendations [38,42]. Some dietary guidelines do recommend nutrient supplementation in general
if the nutrient target cannot be met through diet alone; therefore, this option should be considered
on an individual basis [38]. Additionally, some patients have an intolerance to some forms of dietary
fibre and/or other comorbidities which require a limitation or modification of dietary fibre intake [43].
These patients should receive individualised advice with follow-up to help achieve the best outcomes
and management of potential ongoing symptoms.
Nutrients 2018, 10, 137 15 of 18
4.2.4. Detailed Justification
Subgroup considerations: People with low-socioeconomic backgrounds are likely to require further
support to achieve a high dietary fibre diet as this sub-group may have a poorer quality of diet at
baseline, and have less resources to access dietary support services [44]. A high dietary fibre intake
or specific high fibre foods may also be contraindicated in patients with additional comorbidities,
particularly other diseases of the gastrointestinal tract or kidneys; and therefore, recommendations for
these subgroups should be individualised.
Implementation considerations: Although the recommendation of achieving a high dietary fibre diet
may easily be made, patients may not be aware of what constitutes a high fibre diet and how it can be
achieved [45].
Monitoring and evaluation: Patients should be linked with dietary support services following
discharge so they can be monitored and supported to achieve sustained dietary change [41].
4.3. Research Priorities
Large, well-designed RCTs examining dietary management of diverticulitis are a priority area for
health services due to substantially increasing rates of diverticulitis and associated health care costs [6].
This review provides proof of concept that dietary intervention is able to beneficially impact upon
patient outcomes in the acute and post-acute phase. For both research questions, there is a strong
need to increase the certainty in the body of evidence, particularly for the high priority outcomes such
as recovery, health service use, reoccurrence, patient quality of life and gastrointestinal symptoms.
Future RCTs should use objective measures, blinded randomisation and allocation techniques as well
as objective and/or blinded outcome assessors. Additionally, in a clinical scenario where there are
multiple contributing factors to these outcomes, it is essential that potential confounders are measured
and accounted for, including antibiotics use, level of inflammation, adherence, smoking, BMI and
patient symptoms severity. There is emerging evidence for other risk factors having a role in the
progression of the disease, such as serum vitamin D, nonsteroidal anti-inflammatory drugs, ethnicity
and inherited diseases such as EDS, which also warrant further examination [46]. The large range
of risk factors for diverticular disease will vary between individuals, supporting studies which used
an individualized approach for management beyond standardized prescription of dietary fibre intake.
Studies demonstrating the cost-effectiveness of liberalised versus restricted diets would be helpful
in translation to practice, but as the “intervention” of a liberalised diet incurs no additional cost,
this would not be a priority. However, identifying cost-effective methods of helping individuals
to achieve long-term, sustainable high dietary fibre intakes is of much higher priority, as this will
require significant redirection of nutrition resources which are already tightly strained in most health
services. Alternative cost-effective options, including telehealth methods, should be investigated for
appropriateness and efficacy in this population. There is a need to build evidence to determine whether
a high dietary fibre diet alone is achievable and effective in improving outcomes, or whether dietary
fibre supplementation should be used, and if so, the quantity and type needs further exploration.
Finally, although probiotics may be used by patients, there is no evidence yet supporting their
clinical efficacy in populations with a history of acute, uncomplicated diverticulitis. Therefore, further
RCTs examining the efficacy and safety of this treatment option in addition to high dietary fibre intakes
are needed.
4.4. Limitations
The body of evidence is primarily limited by the absence of well conducted RCTs; but also by
existing studies using varied diagnostic methods used across studies, combining intervention factors
such as dietary fibre restrictions and types of antibiotics, and few using Computed Tomography
for diagnosis, which is considered the gold standard diagnostic technique for acute, uncomplicated
diverticulitis. This suggests the sample populations may have included patients with other similar
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presenting conditions such as irritable bowel syndrome, and studies may have included some patients
with complicated as opposed to uncomplicated diverticulitis. As there are only a few RCTs examining
both clinical research questions, this lack of evidence significantly decreased the confidence in the
evidence for the treatment options, also preventing pooling of data through meta-analysis. The GRADE
approach was used as the best-practice method to evaluate the body of evidence to inform treatment
decisions. However, it should be noted that although the approach was used to make recommendations,
this was made by the current review authors and not a robust multidisciplinary guideline panel.
Additionally, it should be noted due to the very low quality of existing evidence, both clinical
recommendations may change when higher quality evidence becomes available [37].
5. Conclusions
For a clinical topic of significant importance, the current body of evidence is small and of low
quality for the dietary management of acute, uncomplicated diverticulitis and further research should
be considered a priority area for health fundeing and service organisations internationally. However,
considering the feasibility of options and values of stakeholders, recommendations for populations
could be established for each clinical question. The results of this systematic review and GRADE
assessment conditionally recommend the use of liberalised diets as opposed to dietary restrictions for
adults with acute, uncomplicated diverticulitis. It also strongly recommends a high dietary fibre diet,
which meets individual nutrient recommendations, with or without dietary fibre supplementation,
after the acute episode has resolved. As this is based on available evidence which is of poor quality,
recommendations may change with the availability of new higher quality evidence, which is strongly
needed to better inform practice. Additionally, patients with contraindicating comorbidities or
symptoms should be supported with individualised nutrition recommendations.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/10/2/137/s1,
Online Supplementary Material 1: Search Strategy; Online Supplementary Material 2: Cochrane Risk of Bias
Assessment; Online Supplementary Material 3: GRADE recommendation.
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